Cationic Lys53-C5aa endolysin modification boosts anti-Vibrio activity, disrupts membranes, and enhances seafood safety
Background
Endolysins are phage-derived enzymes that specifically degrade the peptidoglycan layer of bacterial cell walls, offering a promising alternative to conventional antibiotics. However, their application against Gram-negative bacteria is severely limited by the outer membrane (OM) barrier, which prevents access to the cell wall. This structural challenge necessitates modifications to enable endolysins to penetrate the OM and exert their lytic activity. Addressing this gap, researchers are exploring cationic peptide fusions to enhance endolysin efficacy against problematic Gram-negative pathogens like Vibrio parahaemolyticus, a major cause of seafood-borne illness.
Study Design
Researchers modified the endolysin Lys53 from phage vB_VpaS_1601 by fusing cationic peptides to its C-terminus, creating the engineered protein Lys53-C5aa. They evaluated its lytic activity against Vibrio parahaemolyticus at a concentration of 6.4 μM over 30 min, assessing bacterial reduction (log CFU/mL). The study also investigated its lysis spectrum, optimal temperature and pH ranges, and mechanisms of action through OM permeability assays, nucleic acid leakage measurements, scanning electron microscopy (SEM), and atomic force microscopy (AFM). Furthermore, Lys53-C5aa's effects on V. parahaemolyticus biofilm formation and its ability to reduce bacterial counts in contaminated oysters and Pacific white shrimp at 4 °C and 25 °C were tested.
Results
The engineered endolysin Lys53-C5aa demonstrated significantly enhanced anti-Vibrio parahaemolyticus activity, achieving a 3.51 log CFU/mL reduction at 6.4 μM within 30 min, alongside a broader lysis spectrum compared to its native form. It maintained optimal lytic activity across a wide temperature range of 4 to 65 °C and a pH range of 5 to 10. Mechanistically, Lys53-C5aa significantly enhanced the OM permeability of V. parahaemolyticus, leading to substantial leakage of intracellular nucleic acids, which peaked at 110.5 ng/μL after 75 min. SEM and AFM analyses confirmed that Lys53-C5aa directly disrupted the structural integrity of the bacterial cells. Beyond planktonic bacteria, Lys53-C5aa exhibited strong anti-biofilm effects, showing 41.83% removal and 61.01% inhibition of V. parahaemolyticus biofilms. > In practical applications, Lys53-C5aa effectively reduced V. parahaemolyticus counts in oysters by 2.14 log CFU/g (4 °C) and 2.40 log CFU/g (25 °C), and in Pacific white shrimp by 2.21 log CFU/g (4 °C) and 2.69 log CFU/g (25 °C).
Key Findings
- Engineered Lys53-C5aa reduced V. parahaemolyticus by 3.51 log CFU/mL at 6.4 μM within 30 min.
- Lys53-C5aa enhanced outer membrane permeability, causing 110.5 ng/μL nucleic acid leakage at 75 min.
- The endolysin showed 41.83% biofilm removal and 61.01% biofilm inhibition.
- Lys53-C5aa reduced V. parahaemolyticus in oysters by up to 2.40 log CFU/g.
- Lys53-C5aa reduced V. parahaemolyticus in shrimp by up to 2.69 log CFU/g.
Why It Matters
This research presents a significant step forward in developing novel antimicrobials against Gram-negative bacteria, overcoming the critical outer membrane barrier that limits many endolysins. Lys53-C5aa's broad activity across diverse temperatures and pH levels makes it highly versatile for various applications. Its efficacy in reducing Vibrio parahaemolyticus contamination in seafood directly addresses a major public health and food safety concern, offering a promising, non-antibiotic solution for food preservation. This modified endolysin could be integrated into food processing protocols or packaging to enhance safety, potentially reducing the reliance on chemical preservatives and combating antibiotic resistance in the food chain. Further development could lead to a usable protocol for industrial application, moving beyond the current lab-scale demonstrations.
lys53-c5aa
endolysin
vibrio-parahaemolyticus
antimicrobial
seafood-safety
membrane-disruption